[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100488185":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":40,"responsibleParty":57,"collaborators":25,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":25,"studyType":75,"phases":76,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"University of Monastir","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"atherolive-drug","ACTIVE_COMPARATOR","The patient will be assigned to one of two treatments (atherolive ) using a computer-generated randomization list (1: 1 allocation). The investigator who has the randomization code is not involved in other study procedures and does not interact with participants. The study drug (atherolive) will be prescribed at a dose of 400 mg, once a day for 3 months.",[13],"Drug: atherolive-drug",{"label":15,"type":16,"description":17,"interventionNames":18},"atherolive-placebo","PLACEBO_COMPARATOR","The patient will be assigned to one of two treatments using a computer-generated randomization list (1: 1 allocation). The investigator who has the randomization code is not involved in other study procedures and does not interact with participants. The study drug (atherolive-placebo) will be prescribed at a dose of 400 mg, once a day for 3 months.",[19],"Drug: Placebo Atherolive",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","The patient will be assigned to one of two treatments (atherolive ) using a computer-generated randomization list (1: 1 allocation). The investigator who has the randomization code is not involved in other study procedures and does not interact with participants. The study drug (atherol) will be prescribed at a dose of 400 mg, once a day for 3 months.",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo Atherolive","The patient will be assigned to one of two treatments using a computer-generated randomization list (1: 1 allocation). The investigator who has the randomization code is not involved in other study procedures and does not interact with participants. Placebo will be prescribed at a dose of 400 mg, once a day for 3 months.",[15],[31,37],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"Nouira semir, Pr","CONTACT","73106046","216","semir.nouira@rns.tn",{"name":38,"role":33,"phone":34,"phoneExt":35,"email":39},"Bel Hadj Ali khaoula, MD","belhadjalikhaoula@yahoo.fr",[41],{"facility":42,"status":43,"city":44,"state":25,"zip":25,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"University Hospital Fattouma Bourguiba Monastir","RECRUITING","Monastir","Tunisia","TN",{"type":48,"coordinates":49},"Point",[50,51],10.82617,35.77799,{"lat":51,"lon":50},[54],{"name":55,"role":33,"phone":56,"phoneExt":25,"email":36},"Semir Nouira, Professor","0021673106046",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Pr. Semir Nouira","clinical proffesor","100488185","phase-2-olive-leaf-extracts-in-the-control-of-hypertension-100488185",false,"NCT05636826","Olive Leaf Extracts in the Control of Hypertension","Efficacy of a Treatment Based on Olive Leaf Extracts in the Control of Cardiovascular Risk Factors:Hypertension","Atherolive","Inclusion Criteria:\n\n* patients over 18 years of age with:\n\nArterial hypertension (hypertension)\n\nExclusion Criteria:\n\n* . Exclusion criteria: None.","ALL","18 Years","95 Years",{"count":73,"type":74},500,"ESTIMATED","INTERVENTIONAL",[77,78],"PHASE2","PHASE3","This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital).\n\nPatients over 18 years of age with:\n\nArterial hypertension (hypertension).",[81],"Hypertension",[83],"hypertension","2024-11-05",{"date":86,"type":87},"2024-11-08","ACTUAL",{"date":89,"type":87},"2023-12-30",{"date":91,"type":74},"2025-12-30",{"name":5,"class":6},1]